TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma
Clinical and Translational Science · 2023-10 · 16 (10) · 1957-1971
DOI: 10.1111/cts.13604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 10.08.2023. Verfasst von Hao Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Ferroptosis, Glioma, Protein Disulfide Reductase (Glutathione). Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ferroptosis is an iron‐dependent cell death process mainly triggered by reactive oxygen species (ROS) and lipid peroxidation. Thioredoxin domain protein 12 (TXNDC12) promotes the development of some tumors; however, its function in tumor ferroptosis remains unclear. In this study, we found that knockdown of TXNDC12 promoted erastin‐induced increase in ROS, lipid peroxidation, and Fe 2+ levels, and decreased glutathione content. TXNDC12 is involved in ferroptosis by regulating SLC7A11. Further studies showed that TXNDC12 knockdown promoted an erastin‐induced decrease in glioma cell viability. Overall, TXNDC12 played a significant role in ferroptosis by modulating SLC7A11 expression. Thus, TXNDC12 and ferroptosis may provide new targets for the treatment of gliomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Xiaobing Jiang
Zitieren
APA
Yu, H., Zhu, K., Wang, M., & Jiang, X. (2023). TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma. Clinical and Translational Science, 16(10), 1957-1971. https://doi.org/10.1111/cts.13604
Vancouver
Yu H, Zhu K, Wang M, Jiang X. TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma. Clinical and Translational Science. 2023;16(10):1957-1971. doi:10.1111/cts.13604
BibTeX
@article{Yu2023,
author = {Yu, Hao and Zhu, Kai and Wang, Minjie and Jiang, Xiaobing},
title = {TXNDC12 knockdown promotes ferroptosis by modulating SLC7A11 expression in glioma},
journal = {Clinical and Translational Science},
year = {2023},
volume = {16},
number = {10},
pages = {1957--1971},
doi = {10.1111/cts.13604}
}
EUVIMED